62846 Efficacy of deucravacitinib in psoriasis by baseline total body surface area: post hoc analysis of the randomized, double-blind, placebo-controlled, phase 3b/4 PSORIATYK Scalp trial — Andrew Blauvelt (2025) | RDL Network
62846 Efficacy of deucravacitinib in psoriasis by baseline total body surface area: post hoc analysis of the randomized, double-blind, placebo-controlled, phase 3b/4 PSORIATYK Scalp trial
Christopher Em Griffiths, Matthias Hoffmann, Andrew Blauvelt, Eugene Balagula, Andrew Napoli, Chun-Yen Cheng, Rachel Dyme, Virginia Hala, Andreas Pinter, Mark Lebwohl
Todd W. Rice, Arthur P. Wheeler, Gordon R. Bernard, Jean Louis Vincent, Derek C. Angus, Naoki Aikawa, Ignace Demeyer, Stephen M. Sainati, Nicholas Amlot, Charlie Cao, Masayuki Ii, Hideyasu Matsuda, Kouji Mouri, Jon Cohen
Andrew X. Zhu, Olivier Rosmorduc, T.R. Jeffry Evans, Paul J. Ross, Armando Santoro, Flair José Carrilho, Jordi Bruix, Shukui Qin, Paul J. Thuluvath, Josep M. Llovet, Marie-Aude LeBerre, Markus Jensen, Gerold Meinhardt, Yoon‐Koo Kang
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.